Literature DB >> 23313050

Nek7 kinase accelerates microtubule dynamic instability.

Sivan Cohen1, Adva Aizer, Yaron Shav-Tal, Amiel Yanai, Benny Motro.   

Abstract

The NIMA-related kinases (NRK or Nek) are emerging as conserved and crucial regulators of mitosis and cilia formation. The microtubule (MT) network has long been suspected as a major target of the Neks. However, the underlying mechanism remains unclear. Using the PlusTipTracker software, recently developed by the Danuser group, we followed the consequences of alterations in Nek7 levels on MT dynamic instability. siRNA-mediated downregulation of Nek7 in HeLa cells resulted in lower speeds of MT growth and catastrophe, reduction of the relative time spent in catastrophe, and considerably lowered the overall MT dynamicity. Co-expression of Nek7 with the siRNA treatment rescued the MT phenotypes, while ectopic overexpression of Nek7 yielded inverse characteristics compared to Nek7 downregulation. MT dynamics in mouse embryonic fibroblasts derived from targeted null mutants for Nek7 recapitulated the siRNA downregulation phenotypes. Precise MT dynamic instability is critical for accurate shaping of the mitotic spindle and for cilium formation, and higher MT dynamicity is associated with tumorigenicity. Thus, our results can supply a mechanistic explanation for Nek involvement in these processes.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23313050     DOI: 10.1016/j.bbamcr.2012.12.021

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  19 in total

1.  Human Nek7-interactor RGS2 is required for mitotic spindle organization.

Authors:  Edmarcia Elisa de Souza; Heidi Hehnly; Arina Marina Perez; Gabriela Vaz Meirelles; Juliana Helena Costa Smetana; Stephen Doxsey; Jörg Kobarg
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 2.  "Stop Ne(c)king around": How interactomics contributes to functionally characterize Nek family kinases.

Authors:  Gabriela Vaz Meirelles; Arina Marina Perez; Edmárcia Elisa de Souza; Fernanda Luisa Basei; Priscila Ferreira Papa; Talita Diniz Melo Hanchuk; Vanessa Bomfim Cardoso; Jörg Kobarg
Journal:  World J Biol Chem       Date:  2014-05-26

3.  C. elegans NIMA-related kinases NEKL-2 and NEKL-3 are required for the completion of molting.

Authors:  John Yochem; Vladimir Lažetić; Leslie Bell; Lihsia Chen; David Fay
Journal:  Dev Biol       Date:  2014-12-16       Impact factor: 3.582

Review 4.  NEK7: a new target for the treatment of multiple tumors and chronic inflammatory diseases.

Authors:  Jin Wang; Simeng Chen; Min Liu; Min Zhang; Xiaoyi Jia
Journal:  Inflammopharmacology       Date:  2022-07-13       Impact factor: 5.093

5.  A Genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Screen Identifies NEK7 as an Essential Component of NLRP3 Inflammasome Activation.

Authors:  Jonathan L Schmid-Burgk; Dhruv Chauhan; Tobias Schmidt; Thomas S Ebert; Julia Reinhardt; Elmar Endl; Veit Hornung
Journal:  J Biol Chem       Date:  2015-11-09       Impact factor: 5.157

6.  The co-chaperone UNC45A is essential for the expression of mitotic kinase NEK7 and tumorigenesis.

Authors:  Nada H Eisa; Yasmeen Jilani; Kashish Kainth; Priscilla Redd; Su Lu; Oulia Bougrine; Houssein Abdul Sater; Chaitanya A Patwardhan; Austin Shull; Huidong Shi; Kebin Liu; Nehal M Elsherbiny; Laila A Eissa; Mamdouh M El-Shishtawy; Anatolij Horuzsko; Roni Bollag; Nita Maihle; Joan Roig; Hasan Korkaya; John K Cowell; Ahmed Chadli
Journal:  J Biol Chem       Date:  2019-02-08       Impact factor: 5.157

7.  Identification of interphase functions for the NIMA kinase involving microtubules and the ESCRT pathway.

Authors:  Meera Govindaraghavan; Sarah Lea McGuire Anglin; Kuo-Fang Shen; Nandini Shukla; Colin P De Souza; Stephen A Osmani
Journal:  PLoS Genet       Date:  2014-03-27       Impact factor: 5.917

8.  EML4-ALK V3 oncogenic fusion proteins promote microtubule stabilization and accelerated migration through NEK9 and NEK7.

Authors:  Laura O'Regan; Giancarlo Barone; Rozita Adib; Chang Gok Woo; Hui Jeong Jeong; Emily L Richardson; Mark W Richards; Patricia A J Muller; Spencer J Collis; Dean A Fennell; Jene Choi; Richard Bayliss; Andrew M Fry
Journal:  J Cell Sci       Date:  2020-05-11       Impact factor: 5.285

9.  NEK1 variants confer susceptibility to amyotrophic lateral sclerosis.

Authors:  Kevin P Kenna; Perry T C van Doormaal; Annelot M Dekker; Nicola Ticozzi; Brendan J Kenna; Frank P Diekstra; Wouter van Rheenen; Kristel R van Eijk; Ashley R Jones; Pamela Keagle; Aleksey Shatunov; William Sproviero; Bradley N Smith; Michael A van Es; Simon D Topp; Aoife Kenna; Jack W Miller; Claudia Fallini; Cinzia Tiloca; Russell L McLaughlin; Caroline Vance; Claire Troakes; Claudia Colombrita; Gabriele Mora; Andrea Calvo; Federico Verde; Safa Al-Sarraj; Andrew King; Daniela Calini; Jacqueline de Belleroche; Frank Baas; Anneke J van der Kooi; Marianne de Visser; Anneloor L M A Ten Asbroek; Peter C Sapp; Diane McKenna-Yasek; Meraida Polak; Seneshaw Asress; José Luis Muñoz-Blanco; Tim M Strom; Thomas Meitinger; Karen E Morrison; Giuseppe Lauria; Kelly L Williams; P Nigel Leigh; Garth A Nicholson; Ian P Blair; Claire S Leblond; Patrick A Dion; Guy A Rouleau; Hardev Pall; Pamela J Shaw; Martin R Turner; Kevin Talbot; Franco Taroni; Kevin B Boylan; Marka Van Blitterswijk; Rosa Rademakers; Jesús Esteban-Pérez; Alberto García-Redondo; Phillip Van Damme; Wim Robberecht; Adriano Chio; Cinzia Gellera; Carsten Drepper; Michael Sendtner; Antonia Ratti; Jonathan D Glass; Jesús S Mora; Nazli A Basak; Orla Hardiman; Albert C Ludolph; Peter M Andersen; Jochen H Weishaupt; Robert H Brown; Ammar Al-Chalabi; Vincenzo Silani; Christopher E Shaw; Leonard H van den Berg; Jan H Veldink; John E Landers
Journal:  Nat Genet       Date:  2016-07-25       Impact factor: 41.307

10.  NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux.

Authors:  Yuan He; Melody Y Zeng; Dahai Yang; Benny Motro; Gabriel Núñez
Journal:  Nature       Date:  2016-01-27       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.